MSB 2.51% 97.0¢ mesoblast limited

Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-193

  1. 291 Posts.
    lightbulb Created with Sketch. 61
    All I'm saying is it's not going to be stopped for overwhelming efficacy at 1st interim readout - defeats the purpose of signing up additional sites.

    Why so aggro? I'm just as invested in msb as you are.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.